APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hydroxyzine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Hydroxyzine Industry Growth and Trends Forecast to 2032

27 December 202590 pages

Choose your research edition.

Industry ResearchHydroxyzine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Hydroxyzine Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Hydroxyzine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hydroxyzine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Hydroxyzine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Hydroxyzine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Hydroxyzine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Hydroxyzine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hydroxyzine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hydroxyzine include GSK, Impax Laboratories, N&R Industries, Novartis, Pfizer, Piramal Group (Piramal Healthcare UK Limited), Shanghai Ruizheng Chemical Technology, Teva Pharmaceuticals and Alliance Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Hydroxyzine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hydroxyzine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hydroxyzine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hydroxyzine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Hydroxyzine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hydroxyzine Market by Company

GSK

Impax Laboratories

N&R Industries

Novartis

Pfizer

Piramal Group (Piramal Healthcare UK Limited)

Shanghai Ruizheng Chemical Technology

Teva Pharmaceuticals

Alliance Pharma

Hydroxyzine Segment by Type

Tablets

Capsules

Other

Hydroxyzine Segment by Application

Hospitals

Retail Pharmacy

Hydroxyzine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxyzine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hydroxyzine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxyzine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hydroxyzine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Hydroxyzine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablets Table 2. Major Company of Capsules Table 3. Major Company of Other Table 4. Global Hydroxyzine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Hydroxyzine Sales by Type (2021-2026) & (K Units) Table 6. Global Hydroxyzine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Hydroxyzine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Hydroxyzine Sales Market Share in Value by Type (2021-2026) Table 9. Global Hydroxyzine Price by Type (2021-2026) & (US$/Unit) Table 10. Global Hydroxyzine Sales by Type (2027-2032) & (K Units) Table 11. Global Hydroxyzine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Hydroxyzine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Hydroxyzine Sales Market Share in Value by Type (2027-2032) Table 14. Global Hydroxyzine Price by Type (2027-2032) & (US$/Unit) Table 15. North America Hydroxyzine Sales by Type (2021-2026) & (K Units) Table 16. North America Hydroxyzine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Hydroxyzine Sales by Type (2021-2026) & (K Units) Table 18. Europe Hydroxyzine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Hydroxyzine Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Hydroxyzine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Hydroxyzine Sales by Type (2021-2026) & (K Units) Table 22. Latin America Hydroxyzine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Hydroxyzine Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Hydroxyzine Sales by Type (2021-2026) & (US$ Million) Table 25. Hydroxyzine Industry Trends Table 26. Hydroxyzine Industry Drivers Table 27. Hydroxyzine Industry Opportunities and Challenges Table 28. Hydroxyzine Industry Restraints Table 29. Global Hydroxyzine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Hydroxyzine Revenue Market Share by Company (2021-2026) Table 31. Global Hydroxyzine Sales by Company (2021-2026) & (K Units) Table 32. Global Hydroxyzine Sales Share by Company (2021-2026) Table 33. Global Hydroxyzine Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Hydroxyzine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Hydroxyzine Major Company Production Sites and Headquarters Table 36. Global Hydroxyzine Company, Product Type & Application Table 37. Global Hydroxyzine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Hydroxyzine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Hydroxyzine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Hydroxyzine Sales by Region (2021-2026) & (K Units) Table 42. Global Hydroxyzine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Hydroxyzine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Hydroxyzine Sales Market Share in Value by Region (2021-2026) Table 45. Global Hydroxyzine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Hydroxyzine Sales by Region (2027-2032) & (K Units) Table 47. Global Hydroxyzine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Hydroxyzine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Hydroxyzine Sales Market Share in Value by Region (2027-2032) Table 50. Global Hydroxyzine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Hydroxyzine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Hydroxyzine Sales by Application (2021-2026) & (K Units) Table 53. Global Hydroxyzine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Hydroxyzine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Hydroxyzine Sales Market Share in Value by Application (2021-2026) Table 56. Global Hydroxyzine Price by Application (2021-2026) & (US$/Unit) Table 57. Global Hydroxyzine Sales by Application (2027-2032) & (K Units) Table 58. Global Hydroxyzine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Hydroxyzine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Hydroxyzine Sales Market Share in Value by Application (2027-2032) Table 61. Global Hydroxyzine Price by Application (2027-2032) & (US$/Unit) Table 62. North America Hydroxyzine Sales by Application (2021-2026) & (K Units) Table 63. North America Hydroxyzine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Hydroxyzine Sales by Application (2021-2026) & (K Units) Table 65. Europe Hydroxyzine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Hydroxyzine Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Hydroxyzine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Hydroxyzine Sales by Application (2021-2026) & (K Units) Table 69. Latin America Hydroxyzine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Hydroxyzine Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Hydroxyzine Sales by Application (2021-2026) & (US$ Million) Table 72. GSK Company Information Table 73. GSK Business Overview Table 74. GSK Hydroxyzine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. GSK Hydroxyzine Product Portfolio Table 76. GSK Recent Development Table 77. Impax Laboratories Company Information Table 78. Impax Laboratories Business Overview Table 79. Impax Laboratories Hydroxyzine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Impax Laboratories Hydroxyzine Product Portfolio Table 81. Impax Laboratories Recent Development Table 82. N&R Industries Company Information Table 83. N&R Industries Business Overview Table 84. N&R Industries Hydroxyzine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. N&R Industries Hydroxyzine Product Portfolio Table 86. N&R Industries Recent Development Table 87. Novartis Company Information Table 88. Novartis Business Overview Table 89. Novartis Hydroxyzine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Novartis Hydroxyzine Product Portfolio Table 91. Novartis Recent Development Table 92. Pfizer Company Information Table 93. Pfizer Business Overview Table 94. Pfizer Hydroxyzine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Pfizer Hydroxyzine Product Portfolio Table 96. Pfizer Recent Development Table 97. Piramal Group (Piramal Healthcare UK Limited) Company Information Table 98. Piramal Group (Piramal Healthcare UK Limited) Business Overview Table 99. Piramal Group (Piramal Healthcare UK Limited) Hydroxyzine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Piramal Group (Piramal Healthcare UK Limited) Hydroxyzine Product Portfolio Table 101. Piramal Group (Piramal Healthcare UK Limited) Recent Development Table 102. Shanghai Ruizheng Chemical Technology Company Information Table 103. Shanghai Ruizheng Chemical Technology Business Overview Table 104. Shanghai Ruizheng Chemical Technology Hydroxyzine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Shanghai Ruizheng Chemical Technology Hydroxyzine Product Portfolio Table 106. Shanghai Ruizheng Chemical Technology Recent Development Table 107. Teva Pharmaceuticals Company Information Table 108. Teva Pharmaceuticals Business Overview Table 109. Teva Pharmaceuticals Hydroxyzine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Teva Pharmaceuticals Hydroxyzine Product Portfolio Table 111. Teva Pharmaceuticals Recent Development Table 112. Alliance Pharma Company Information Table 113. Alliance Pharma Business Overview Table 114. Alliance Pharma Hydroxyzine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Alliance Pharma Hydroxyzine Product Portfolio Table 116. Alliance Pharma Recent Development Table 117. North America Hydroxyzine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. North America Hydroxyzine Sales by Country (2021-2026) & (K Units) Table 119. North America Hydroxyzine Sales Market Share by Country (2021-2026) Table 120. North America Hydroxyzine Sales Forecast by Country (2027-2032) & (K Units) Table 121. North America Hydroxyzine Sales Market Share Forecast by Country (2027-2032) Table 122. North America Hydroxyzine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. North America Hydroxyzine Market Size by Country (2021-2026) & (US$ Million) Table 124. North America Hydroxyzine Market Share by Country (2021-2026) Table 125. North America Hydroxyzine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. North America Hydroxyzine Market Share Forecast by Country (2027-2032) Table 127. Europe Hydroxyzine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Europe Hydroxyzine Sales by Country (2021-2026) & (K Units) Table 129. Europe Hydroxyzine Sales Market Share by Country (2021-2026) Table 130. Europe Hydroxyzine Sales Forecast by Country (2027-2032) & (K Units) Table 131. Europe Hydroxyzine Sales Market Share Forecast by Country (2027-2032) Table 132. Europe Hydroxyzine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Europe Hydroxyzine Market Size by Country (2021-2026) & (US$ Million) Table 134. Europe Hydroxyzine Market Share by Country (2021-2026) Table 135. Europe Hydroxyzine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Europe Hydroxyzine Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Hydroxyzine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Hydroxyzine Sales by Country (2021-2026) & (K Units) Table 139. Asia-Pacific Hydroxyzine Sales Market Share by Country (2021-2026) Table 140. Asia-Pacific Hydroxyzine Sales Forecast by Country (2027-2032) & (K Units) Table 141. Asia-Pacific Hydroxyzine Sales Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Hydroxyzine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Hydroxyzine Market Size by Country (2021-2026) & (US$ Million) Table 144. Asia-Pacific Hydroxyzine Market Share by Country (2021-2026) Table 145. Asia-Pacific Hydroxyzine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Asia-Pacific Hydroxyzine Market Share Forecast by Country (2027-2032) Table 147. Latin America Hydroxyzine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Latin America Hydroxyzine Sales by Country (2021-2026) & (K Units) Table 149. Latin America Hydroxyzine Sales Market Share by Country (2021-2026) Table 150. Latin America Hydroxyzine Sales Forecast by Country (2027-2032) & (K Units) Table 151. Latin America Hydroxyzine Sales Market Share Forecast by Country (2027-2032) Table 152. Latin America Hydroxyzine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Latin America Hydroxyzine Market Size by Country (2021-2026) & (US$ Million) Table 154. Latin America Hydroxyzine Market Share by Country (2021-2026) Table 155. Latin America Hydroxyzine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Latin America Hydroxyzine Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Hydroxyzine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Hydroxyzine Sales by Country (2021-2026) & (K Units) Table 159. Middle East and Africa Hydroxyzine Sales Market Share by Country (2021-2026) Table 160. Middle East and Africa Hydroxyzine Sales Forecast by Country (2027-2032) & (K Units) Table 161. Middle East and Africa Hydroxyzine Sales Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Hydroxyzine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Hydroxyzine Market Size by Country (2021-2026) & (US$ Million) Table 164. Middle East and Africa Hydroxyzine Market Share by Country (2021-2026) Table 165. Middle East and Africa Hydroxyzine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Middle East and Africa Hydroxyzine Market Share Forecast by Country (2027-2032) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Hydroxyzine Distributors List Table 170. Hydroxyzine Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Hydroxyzine Image Figure 2. Global Hydroxyzine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hydroxyzine Market Size (2021-2032) & (US$ Million) Figure 4. Global Hydroxyzine Sales (2021-2032) & (K Units) Figure 5. Tablets Image Figure 6. Global Tablets Sales YoY Growth (2021-2032) & (K Units) Figure 7. Capsules Image Figure 8. Global Capsules Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Hydroxyzine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Hydroxyzine Market Share by Type 2025 VS 2032 Figure 13. North America Hydroxyzine Sales Market Share in Volume by Type in 2025 Figure 14. North America Hydroxyzine Sales Market Share in Value by Type in 2025 Figure 15. Europe Hydroxyzine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Hydroxyzine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Hydroxyzine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Hydroxyzine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Hydroxyzine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Hydroxyzine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Hydroxyzine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Hydroxyzine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Hydroxyzine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospitals Image Figure 26. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 27. Retail Pharmacy Image Figure 28. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Hydroxyzine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Hydroxyzine Market Share by Application 2025 VS 2032 Figure 31. North America Hydroxyzine Sales Market Share in Volume by Application in 2025 Figure 32. North America Hydroxyzine Sales Market Share in Value by Application in 2025 Figure 33. Europe Hydroxyzine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Hydroxyzine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Hydroxyzine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Hydroxyzine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Hydroxyzine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Hydroxyzine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Hydroxyzine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Hydroxyzine Sales Market Share in Value by Application in 2025 Figure 41. North America Hydroxyzine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Hydroxyzine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Hydroxyzine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Hydroxyzine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Hydroxyzine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Hydroxyzine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Hydroxyzine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Hydroxyzine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Hydroxyzine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Hydroxyzine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Hydroxyzine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Hydroxyzine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Hydroxyzine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Hydroxyzine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Hydroxyzine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Hydroxyzine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Hydroxyzine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Hydroxyzine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Hydroxyzine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Hydroxyzine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Hydroxyzine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Hydroxyzine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Capsules
  • Other
Applications
  • Hospitals
  • Retail Pharmacy
Companies covered
  • GSK
  • Impax Laboratories
  • N&R Industries
  • Novartis
  • Pfizer
  • Piramal Group (Piramal Healthcare UK Limited)
  • Shanghai Ruizheng Chemical Technology
  • Teva Pharmaceuticals
  • Alliance Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hydroxyzine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Hydroxyzine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Hydroxyzine Market by Type
  6. 1.3.1 Tablets
  7. 1.3.2 Capsules
  8. 1.3.3 Other
  9. 1.4 Global Hydroxyzine Market Size by Type
  10. 1.4.1 Global Hydroxyzine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Hydroxyzine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Hydroxyzine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Hydroxyzine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Hydroxyzine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Hydroxyzine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Hydroxyzine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Hydroxyzine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Hydroxyzine Industry Trends
  2. 2.2 Hydroxyzine Industry Drivers
  3. 2.3 Hydroxyzine Industry Opportunities and Challenges
  4. 2.4 Hydroxyzine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Hydroxyzine Revenue (2021-2026)
  2. 3.2 Global Top Players by Hydroxyzine Sales (2021-2026)
  3. 3.3 Global Top Players by Hydroxyzine Price (2021-2026)
  4. 3.4 Global Hydroxyzine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hydroxyzine Major Company Production Sites & Headquarters
  6. 3.6 Global Hydroxyzine Company, Product Type & Application
  7. 3.7 Global Hydroxyzine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hydroxyzine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hydroxyzine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hydroxyzine Tier 1, Tier 2, and Tier 3
4 Hydroxyzine Regional Status and Outlook
  1. 4.1 Global Hydroxyzine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Hydroxyzine Historic Market Size by Region
  3. 4.2.1 Global Hydroxyzine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Hydroxyzine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Hydroxyzine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Hydroxyzine Forecasted Market Size by Region
  7. 4.3.1 Global Hydroxyzine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Hydroxyzine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Hydroxyzine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hydroxyzine by Application
  1. 5.1 Hydroxyzine Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Retail Pharmacy
  4. 5.2 Global Hydroxyzine Market Size by Application
  5. 5.2.1 Global Hydroxyzine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Hydroxyzine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Hydroxyzine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Hydroxyzine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Hydroxyzine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Hydroxyzine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Hydroxyzine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Hydroxyzine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Hydroxyzine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Hydroxyzine Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Impax Laboratories
  8. 6.2.1 Impax Laboratories Company Information
  9. 6.2.2 Impax Laboratories Business Overview
  10. 6.2.3 Impax Laboratories Hydroxyzine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Impax Laboratories Hydroxyzine Product Portfolio
  12. 6.2.5 Impax Laboratories Recent Developments
  13. 6.3 N&R Industries
  14. 6.3.1 N&R Industries Company Information
  15. 6.3.2 N&R Industries Business Overview
  16. 6.3.3 N&R Industries Hydroxyzine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 N&R Industries Hydroxyzine Product Portfolio
  18. 6.3.5 N&R Industries Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Hydroxyzine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Hydroxyzine Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Hydroxyzine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Hydroxyzine Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Piramal Group (Piramal Healthcare UK Limited)
  32. 6.6.1 Piramal Group (Piramal Healthcare UK Limited) Company Information
  33. 6.6.2 Piramal Group (Piramal Healthcare UK Limited) Business Overview
  34. 6.6.3 Piramal Group (Piramal Healthcare UK Limited) Hydroxyzine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Piramal Group (Piramal Healthcare UK Limited) Hydroxyzine Product Portfolio
  36. 6.6.5 Piramal Group (Piramal Healthcare UK Limited) Recent Developments
  37. 6.7 Shanghai Ruizheng Chemical Technology
  38. 6.7.1 Shanghai Ruizheng Chemical Technology Company Information
  39. 6.7.2 Shanghai Ruizheng Chemical Technology Business Overview
  40. 6.7.3 Shanghai Ruizheng Chemical Technology Hydroxyzine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shanghai Ruizheng Chemical Technology Hydroxyzine Product Portfolio
  42. 6.7.5 Shanghai Ruizheng Chemical Technology Recent Developments
  43. 6.8 Teva Pharmaceuticals
  44. 6.8.1 Teva Pharmaceuticals Company Information
  45. 6.8.2 Teva Pharmaceuticals Business Overview
  46. 6.8.3 Teva Pharmaceuticals Hydroxyzine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Teva Pharmaceuticals Hydroxyzine Product Portfolio
  48. 6.8.5 Teva Pharmaceuticals Recent Developments
  49. 6.9 Alliance Pharma
  50. 6.9.1 Alliance Pharma Company Information
  51. 6.9.2 Alliance Pharma Business Overview
  52. 6.9.3 Alliance Pharma Hydroxyzine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Alliance Pharma Hydroxyzine Product Portfolio
  54. 6.9.5 Alliance Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Hydroxyzine Sales by Country
  2. 7.1.1 North America Hydroxyzine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Hydroxyzine Sales by Country (2021-2026)
  4. 7.1.3 North America Hydroxyzine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Hydroxyzine Market Size by Country
  6. 7.2.1 North America Hydroxyzine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Hydroxyzine Market Size by Country (2021-2026)
  8. 7.2.3 North America Hydroxyzine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Hydroxyzine Sales by Country
  2. 8.1.1 Europe Hydroxyzine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Hydroxyzine Sales by Country (2021-2026)
  4. 8.1.3 Europe Hydroxyzine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Hydroxyzine Market Size by Country
  6. 8.2.1 Europe Hydroxyzine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Hydroxyzine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Hydroxyzine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Hydroxyzine Sales by Country
  2. 9.1.1 Asia-Pacific Hydroxyzine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Hydroxyzine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Hydroxyzine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Hydroxyzine Market Size by Country
  6. 9.2.1 Asia-Pacific Hydroxyzine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Hydroxyzine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Hydroxyzine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Hydroxyzine Sales by Country
  2. 10.1.1 South America Hydroxyzine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Hydroxyzine Sales by Country (2021-2026)
  4. 10.1.3 South America Hydroxyzine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Hydroxyzine Market Size by Country
  6. 10.2.1 South America Hydroxyzine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Hydroxyzine Market Size by Country (2021-2026)
  8. 10.2.3 South America Hydroxyzine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Hydroxyzine Sales by Country
  2. 11.1.1 Middle East and Africa Hydroxyzine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Hydroxyzine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Hydroxyzine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Hydroxyzine Market Size by Country
  6. 11.2.1 Middle East and Africa Hydroxyzine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Hydroxyzine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Hydroxyzine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Hydroxyzine Value Chain Analysis
  2. 12.1.1 Hydroxyzine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Hydroxyzine Production Mode & Process
  7. 12.2 Hydroxyzine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Hydroxyzine Distributors
  10. 12.2.3 Hydroxyzine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst